These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33418930)

  • 1. Therapeutic Potential of Antimicrobial Peptides in Polymicrobial Biofilm-Associated Infections.
    Batoni G; Maisetta G; Esin S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418930
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kiedrowski MR; Gaston JR; Kocak BR; Coburn SL; Lee S; Pilewski JM; Myerburg MM; Bomberger JM
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111629
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between Pseudomonas aeruginosa and Staphylococcus aureus during co-cultivations and polymicrobial infections.
    Nguyen AT; Oglesby-Sherrouse AG
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6141-6148. PubMed ID: 27236810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics.
    Orazi G; Ruoff KL; O'Toole GA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31363032
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms.
    Orazi G; Jean-Pierre F; O'Toole GA
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease.
    Gaglione R; Cesaro A; Dell'Olmo E; Di Girolamo R; Tartaglione L; Pizzo E; Arciello A
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.
    Price CE; Brown DG; Limoli DH; Phelan VV; O'Toole GA
    J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31792010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The innate immune protein calprotectin promotes Pseudomonas aeruginosa and Staphylococcus aureus interaction.
    Wakeman CA; Moore JL; Noto MJ; Zhang Y; Singleton MD; Prentice BM; Gilston BA; Doster RS; Gaddy JA; Chazin WJ; Caprioli RM; Skaar EP
    Nat Commun; 2016 Jun; 7():11951. PubMed ID: 27301800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Help, hinder, hide and harm: what can we learn from the interactions between
    Limoli DH; Hoffman LR
    Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
    Silva E; Monteiro R; Grainha T; Alves D; Pereira MO; Sousa AM
    Front Cell Infect Microbiol; 2020; 10():441. PubMed ID: 32974221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.
    Jorge P; Grzywacz D; Kamysz W; Lourenço A; Pereira MO
    PLoS One; 2017; 12(3):e0174654. PubMed ID: 28355248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Biofilm Effects of Synthetic Antimicrobial Peptides Against Drug-Resistant
    Park SC; Lee MY; Kim JY; Kim H; Jung M; Shin MK; Lee WK; Cheong GW; Lee JR; Jang MK
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31842508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain Background, Species Frequency, and Environmental Conditions Are Important in Determining Pseudomonas aeruginosa and Staphylococcus aureus Population Dynamics and Species Coexistence.
    Niggli S; Kümmerli R
    Appl Environ Microbiol; 2020 Sep; 86(18):. PubMed ID: 32651205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo.
    Rozenbaum RT; Su L; Umerska A; Eveillard M; Håkansson J; Mahlapuu M; Huang F; Liu J; Zhang Z; Shi L; van der Mei HC; Busscher HJ; Sharma PK
    J Control Release; 2019 Jan; 293():73-83. PubMed ID: 30465823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Yadav MK; Chae SW; Go YY; Im GJ; Song JJ
    Front Cell Infect Microbiol; 2017; 7():125. PubMed ID: 28459043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.